This book looks at the experiences of different latecomer countries in promoting sustainable health innovation systems to cater to local needs, presenting empirical findings from India, Bangladesh, Vietnam, Kenya, Tanzania and Nigeria.

Reconfiguring Global Health Innovation presents the findings of multi-year research, contrasting experiences of different latecomer countries in building health innovation systems to cater to local needs. It analyses the emerging industrial structures in health innovation as more and more latecomer countries are foraying into what is a highly difficult and technologically intensive sector, with the aim of finding ways and means to balance these promising developments with public health needs worldwide. The bookpresents empirical findings from six countries across Asia and Africa on health innovation, namely, India, Bangladesh, Vietnam, Kenya, Tanzania and Nigeria. The book concludes that the growth of knowledge and the accumulation of capabilities influence the ability of a country to generate wealth.

This book brings together a collection of empirical case studies featuring a wide spectrum of medical innovation. While there is no unique pathway to successful medical innovation, recurring and distinctive features can be observed across different areas of clinical practice. This book examines why medical practice develops so unevenly across and within areas of disease, and how this relates to the underlying conditions of innovation across areas of practice. The contributions contained in this volume adopt a dynamic perspective on medical innovation based on the notion that scientific understanding, technology and clinical practice co-evolve along the co-ordinated search for solutions to medical problems. The chapters follow an historical approach to emphasise that the advancement of medical know-how is a contested, nuanced process, and that it involves a variety of knowledge bases whose evolutionary paths are rooted in the contexts in which they emerge. This book will be of interest to researchers and practitioners concerned with medical innovation, management studies and the economics of innovation. Chapter 5 of this book is freely available as a downloadable Open Access PDF at http://www.taylorfrancis.com under a Creative Commons Attribution-Non Commercial-No Derivatives (CC-BY-NC-ND) 3.0 license.

'This impressive collection offers fascinating new perspectives on the impact of pharmaceutical patents on access to medicines in developing countries. The volume's editors have put together an important book that sets out clearly the challenges to public health in a wide range of national contexts. The book will be a valuable text for all scholars and decision-makers interested in the global politics of intellectual property rights and public health.' – Duncan Matthews, Queen Mary, University of London, UK This up-to-date book examines pharmaceutical development, access to medicines, and the protection of public health in the context of two fundamental changes that the global political economy has undergone since the 1970s, the globalization of trade and production and the increased harmonization of national regulations on intellectual property rights. With authors from eleven different countries presenting case studies of national experiences in Africa, Asia and the Americas, the book analyzes national strategies to promote pharmaceutical innovation, while at the same time assuring widespread access to medicines through generic pharmaceutical production and generic pharmaceutical importation. The expert chapters focus on patents as well as an array of regulatory instruments, including pricing and drug registration policies. Presenting in-depth analysis and original empirical research, this book will strongly appeal to academics and students of intellectual property, international health, international political economy, international development and law.

Steep socioeconomic hierarchy in post-industrial Western society threatens public health because of the physiological consequences of material and psychosocial insecurities and deprivations. Following on from their previous books, the authors continue their exploration of the geography of early mortality from age-related chronic conditions, of risk behaviors and their health outcomes, and of infant and child mortality, all due to rigid hierarchy. They divide the 50 states into those that gave their electoral college votes to Trump and those that gave theirs to Clinton in the 2016 presidential election and compare the two sets for socioeconomic and public health profiles. They deliberately apply only simple standard statistical methods in the public health analyses: t-test, Mann-Whitney test, bivariate regression, and backward stepwise multivariate regression. The book assumes familiarity with basic statistics. The authors argue that the unequal power relations that result in eroding public health in the nation and, in particular, in the Trump-voting states, largely cascade from the collapse of American industry, and they analyze the Cold War roots of that collapse. In two largely independent chapters on economics, they explore both the suppression of countervailing forces, such as organized labor, and the diversion of technical resources to the military as essential foundations to the population-level suffering that expressed itself in the 2016 presidential election. This interdisciplinary book has several primary audiences: creators of public policies, such as legislators and governmental staff, public health professionals and social epidemiologists, economists, labor union professionals, civil rights advocates, political scientists, historians, and students of these disciplines from public health through the social sciences.

Health 4.0 is a term that has derived from the Fourth Industrial Revolution (Industry 4.0), as it pertains to the healthcare industry. This book offers a novel, concise, but at the same time, broad picture of the challenges that the technological revolution has created for the healthcare system. It offers a comprehensive view of health sector actors’ interaction with the emerging new technology, which is disrupting the status quo in health service delivery. It explains how these technological developments impact both society and healthcare governance. Further, the book addresses issues related to key healthcare system stakeholders: the state, patients, medical professionals, and non-governmental organizations. It also examines areas of healthcare system adaptiveness and draws its conclusions by analysing recent health policy changes in different countries across the Americas, Europe, and Asia. The authors offer an innovative approach to the subject by identifying the critical determinants of successful implementation of the Fourth Industrial Revolution’s outcomes in practice, on both a macro- and microlevel. The macrolevel analysis is focused on essential factors of healthcare system adaptiveness for Health 4.0, while the microlevel relates to patients’ expectations with a particular emphasis on senior citizens. The book will appeal to academics, researchers, and students, across a wide range of disciplines, such as health economics, health sciences, public policy, public administration, political science, public governance, and sociology. It will also find an audience among healthcare professionals and health and social policymakers due to its recommendations for implementing Industry 4.0 into a healthcare system.

The application of Artificial Intelligence (AI) in the healthcare sector is certain to boost levels of automation and productivity but, paradoxically, it will also increase the availability of “first line competence.” At the same time as demographic trends are affecting demand for health and social care, the technological developments we are seeing make it highly likely that AI will play a decisive role in tackling the challenges our healthcare systems will encounter. This book reveals systemic connections to tackle questions about the potential impact of AI on future challenges in the healthcare sector. Specifically, it develops practical proposals for ways in which AI can be applied to solve these forthcoming issues. It emphasizes the importance of AI in what is known in the literature as human augmentation. The book’s innovative perspective is apparent in the way it challenges conventional wisdom in the context of several pressing questions, such as: • What opportunities and challenges could arise from the application of AI in the healthcare sector? • How can the philosophy of medicine, viewed from a systemic perspective, help us to understand, explain, and resolve some of the future challenges in the healthcare sector? • How could AI affect inclusive employment opportunities for people with disabilities? The book also contains an underlying argument to the effect that the rational approach adopted by economists is perhaps less rational when applied to a healthcare sector that is crying out for more “first line competence.” The primary readership will be academic, but the book will also appeal to policymakers, consultants, HR departments, healthcare stakeholders, and related practitioners.